vs
Side-by-side financial comparison of Dexcom (DXCM) and Microchip Technology (MCHP). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× Microchip Technology). Dexcom runs the higher net margin — 21.2% vs 5.3%, a 15.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 15.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -5.4%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Microchip Technology Incorporated is an American publicly traded semiconductor corporation that manufactures microcontroller, mixed-signal, analog, and Flash-IP integrated circuits.
DXCM vs MCHP — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $267.3M | $62.7M |
| Gross Margin | 62.9% | 59.6% |
| Operating Margin | 25.6% | 12.8% |
| Net Margin | 21.2% | 5.3% |
| Revenue YoY | 21.6% | 15.6% |
| Net Profit YoY | 153.6% | 217.0% |
| EPS (diluted) | $0.67 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.0B | $970.5M | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $994.2M | $1.2B | ||
| Q2 24 | $1.0B | $1.2B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $62.7M | ||
| Q3 25 | $283.8M | $41.7M | ||
| Q2 25 | $179.8M | $-18.6M | ||
| Q1 25 | $105.4M | $-154.6M | ||
| Q4 24 | $151.7M | $-53.6M | ||
| Q3 24 | $134.6M | $78.4M | ||
| Q2 24 | $143.5M | $129.3M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 59.6% | ||
| Q3 25 | 60.5% | 55.9% | ||
| Q2 25 | 59.5% | 53.6% | ||
| Q1 25 | 56.9% | 51.6% | ||
| Q4 24 | 58.9% | 54.7% | ||
| Q3 24 | 59.7% | 57.4% | ||
| Q2 24 | 62.4% | 59.4% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 12.8% | ||
| Q3 25 | 20.1% | 7.8% | ||
| Q2 25 | 18.4% | 3.0% | ||
| Q1 25 | 12.9% | -10.3% | ||
| Q4 24 | 17.0% | 3.0% | ||
| Q3 24 | 15.3% | 12.6% | ||
| Q2 24 | 15.7% | 17.7% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 5.3% | ||
| Q3 25 | 23.5% | 3.7% | ||
| Q2 25 | 15.5% | -1.7% | ||
| Q1 25 | 10.2% | -15.9% | ||
| Q4 24 | 13.6% | -5.2% | ||
| Q3 24 | 13.5% | 6.7% | ||
| Q2 24 | 14.3% | 10.4% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.06 | ||
| Q3 25 | $0.70 | $0.03 | ||
| Q2 25 | $0.45 | $-0.09 | ||
| Q1 25 | $0.27 | $-0.29 | ||
| Q4 24 | $0.37 | $-0.10 | ||
| Q3 24 | $0.34 | $0.14 | ||
| Q2 24 | $0.35 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $250.7M |
| Total DebtLower is stronger | — | $5.4B |
| Stockholders' EquityBook value | $2.7B | $6.6B |
| Total Assets | $6.3B | $14.3B |
| Debt / EquityLower = less leverage | — | 0.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $250.7M | ||
| Q3 25 | $1.8B | $236.8M | ||
| Q2 25 | $1.2B | $566.5M | ||
| Q1 25 | $904.9M | $771.7M | ||
| Q4 24 | $606.1M | $586.0M | ||
| Q3 24 | $621.2M | $286.1M | ||
| Q2 24 | $939.2M | $315.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.4B | ||
| Q3 25 | — | $5.4B | ||
| Q2 25 | — | $5.5B | ||
| Q1 25 | — | $5.6B | ||
| Q4 24 | — | $6.7B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.2B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $6.6B | ||
| Q3 25 | $2.7B | $6.7B | ||
| Q2 25 | $2.6B | $6.9B | ||
| Q1 25 | $2.3B | $7.1B | ||
| Q4 24 | $2.1B | $6.0B | ||
| Q3 24 | $2.0B | $6.3B | ||
| Q2 24 | $2.4B | $6.4B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $14.3B | ||
| Q3 25 | $7.5B | $14.5B | ||
| Q2 25 | $7.3B | $15.0B | ||
| Q1 25 | $6.8B | $15.4B | ||
| Q4 24 | $6.5B | $15.6B | ||
| Q3 24 | $6.4B | $15.6B | ||
| Q2 24 | $6.8B | $15.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.82× | ||
| Q3 25 | — | 0.80× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | 1.02× | ||
| Q2 24 | — | 0.96× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $341.4M |
| Free Cash FlowOCF − Capex | — | $318.9M |
| FCF MarginFCF / Revenue | — | 26.9% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 5.44× |
| TTM Free Cash FlowTrailing 4 quarters | — | $819.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $341.4M | ||
| Q3 25 | $659.9M | $88.1M | ||
| Q2 25 | $303.0M | $275.6M | ||
| Q1 25 | $183.8M | $205.9M | ||
| Q4 24 | $301.4M | $271.5M | ||
| Q3 24 | $199.5M | $43.6M | ||
| Q2 24 | $279.4M | $377.1M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $318.9M | ||
| Q3 25 | $579.4M | $51.6M | ||
| Q2 25 | $208.9M | $257.7M | ||
| Q1 25 | $96.8M | $191.7M | ||
| Q4 24 | $176.8M | $253.4M | ||
| Q3 24 | $88.3M | $22.8M | ||
| Q2 24 | $213.3M | $304.2M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 26.9% | ||
| Q3 25 | 47.9% | 4.5% | ||
| Q2 25 | 18.1% | 24.0% | ||
| Q1 25 | 9.3% | 19.8% | ||
| Q4 24 | 15.9% | 24.7% | ||
| Q3 24 | 8.9% | 2.0% | ||
| Q2 24 | 21.2% | 24.5% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.9% | ||
| Q3 25 | 6.7% | 3.2% | ||
| Q2 25 | 8.1% | 1.7% | ||
| Q1 25 | 8.4% | 1.5% | ||
| Q4 24 | 11.2% | 1.8% | ||
| Q3 24 | 11.2% | 1.8% | ||
| Q2 24 | 6.6% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 5.44× | ||
| Q3 25 | 2.33× | 2.11× | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 0.56× | ||
| Q2 24 | 1.95× | 2.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
MCHP
| Mixed Signal Microcontrollers | $586.5M | 49% |
| Analog | $322.9M | 27% |
| Other Product Line | $276.6M | 23% |
